The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Aug. 20, 2012
Applicants:

Michael John Bradley Kutryk, Ontario, CA;

Robert J. Cottone, Jr., Davie, FL (US);

Stephen M. Rowland, Miami, FL (US);

Inventors:

Michael John Bradley Kutryk, Ontario, CA;

Robert J. Cottone, Jr., Davie, FL (US);

Stephen M. Rowland, Miami, FL (US);

Assignee:

ORBUS MEDICAL TECHNOLOGY INC, Fort Lauderdale, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/06 (2013.01); A61K 38/39 (2006.01); A61L 27/08 (2006.01); A61L 27/22 (2006.01); A61L 27/30 (2006.01); A61L 27/44 (2006.01); A61L 27/54 (2006.01); A61L 29/10 (2006.01); A61L 29/12 (2006.01); A61L 29/16 (2006.01); A61L 31/04 (2006.01); A61L 31/08 (2006.01); A61L 31/12 (2006.01); A61L 31/16 (2006.01); C12N 5/071 (2010.01); A61K 38/36 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); B82Y 30/00 (2011.01);
U.S. Cl.
CPC ...
A61K 38/39 (2013.01); A61L 27/08 (2013.01); A61L 27/227 (2013.01); A61L 27/303 (2013.01); A61L 27/44 (2013.01); A61L 27/54 (2013.01); A61L 29/103 (2013.01); A61L 29/126 (2013.01); A61L 29/16 (2013.01); A61L 31/047 (2013.01); A61L 31/084 (2013.01); A61L 31/125 (2013.01); A61L 31/16 (2013.01); A61L 2300/256 (2013.01); A61L 2300/416 (2013.01); A61L 2300/422 (2013.01); A61L 2300/606 (2013.01); B82Y 30/00 (2013.01); C12N 5/0692 (2013.01); C12N 2510/00 (2013.01); A61K 38/363 (2013.01); A61K 39/39558 (2013.01); C07K 16/2896 (2013.01); C07K 2317/55 (2013.01);
Abstract

The invention relates to a method for healing blood vessels by stimulating the formation of a confluent endothelial autologous cell layer in vivo on an implantable metallic stent having a lumen and a luminal surface, and an exterior surface. More specifically, the method includes implanting the stent with a coating in a patient in need of thereof; wherein the coating includes one or more layers of a matrix covalently adherent on said luminal and exterior surface of said stent containing one or more pharmaceutical substances on said exterior surface and a therapeutically effective amount of a single type of antibody, antibody fragments or combinations thereof being compatible to binding selectively to a specific cell surface antigen of circulating autologous endothelial progenitor cells in peripheral blood. In addition, genetically engineered endothelial progenitor cells can be captured on said luminal surface of stent in vivo, to proliferate to form rapidly a confluent endothelium in situ.


Find Patent Forward Citations

Loading…